how to get semaglutide with low bmi What is the role of (glucagon-like peptide-1 receptor agonist) in managing high abdominal obesity in individuals Body Mass Index ( BMI)? GLP-1 Use at Lower BMI:

Subcutaneous injection (Ozempic, Wegovy): Ozempic is known to reduce cardiovascular events, whereas, Wegovy injections have shown efficacy in controlling obese and overweight individuals

Since then, liraglutide (Victoza and Saxenda, Novo Nordisk), dulaglutide (Trulicity, Eli Lilly), lixisenatide (Adlyxin, Sanofi-Aventis), semaglutide (Ozempic, Wegovy and Rybelsus, Novo Nordisk) and tirzepatide (Mounjaro and Zepbound, Eli Lilly) have been FDA approved for various indications

Horton New England Journal of Medicine 393(14):p 1409-1419, October 9, 2025

Levity vs other telehealth platforms The broader telehealth landscape includes platforms like WeightCare , Elevate Health , and Medvi , each with distinct approaches to GLP-1 prescribing